Printer Friendly

Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018.

NEW YORK, Dec. 31, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Forecast to 2018

utm_campaign=In_Vitro_Diagnostic

Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018

The microfluidics market is segmented based on materials, products, and applications. This report studies market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices.

The market is expected to grow at a strong CAGR during the study period. This is due to factors such as the rising demand for POC devices, quick return on investments provided by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips. However, factors such as difficulty in incorporation of emerging microfluidic technologies into existing workflows and complex and time consuming regulatory standards are hampering the growth of this market.

The estimated value of the market was calculated based on the materials, (industry) products, and applications revenue. Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on industry, the market is classified into pharmaceutical, in-vitro diagnostics, and drug delivery devices. The pharmaceutical segment is categorized into microfluidics chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The microfluidics chips for lab analytics segment is further classified into toxicity screening, proteomic analysis, gene sequencing, and capillary electrophoresis. In-vitro diagnostics is further segmented into clinical diagnostics, Point-of-Care diagnostics, environmental testing, industrial testing, and agro food testing. The drug delivery devices market is categorized into inhaler nozzles, micro needles, and micro pumps.

Based on applications, the market is categorized into six applications, namely, drug delivery, industrial and environmental, analytical devices, pharmaceutical and life science research, Point-of-Care diagnostics, and clinical and veterinary diagnostics. The Point-of-Care diagnostics segment commands the largest share of the global applications market. It is expected to grow at a strong CAGR during the study period. The large share of this segment is attributed to the increased adoption of microfluidics in Point-of-Care diagnostics by major diagnostic companies such as Roche Diagnostics (Switzerland), Becton Dickinson and Company (U.S.), Abbott Laboratories (U.S.), and Cepheid (U.S.).

North America dominates the market, accounting for around one-third of the share. The leading market share of the North American region is attributed to the presence of a large number of major manufacturers such as, Abbott Laboratories, Agilent Technologies, Caliper Life Sciences (PerkinElmer), and Johnson & Johnson, in this region. Additionally, the rising adoption of microfluidics technology and the increasing rate of new product launches in the North American region are the favorable factors driving the market growth.

Global Microfluidics Market Scenario

Microfluidics Market

Source: Annual Reports, SEC Filings, Expert Interviews, and MarketsandMarkets Analysis

TABLE OF CONTENTS

1 INTRODUCTION 21 1.1 OBJECTIVES OF THE STUDY 21 1.2 REPORT DESCRIPTION 21 1.3 MARKETS COVERED 23 1.4 STAKEHOLDERS 24 1.5 MARKET SCOPE 25 1.6 RESEARCH METHODOLOGY 26 1.6.1 MARKET SIZE ESTIMATION 27 1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION 28 1.6.3 KEY DATA POINTS FROM PRIMARY SOURCES 31 1.6.4 KEY DATA POINTS FROM SECONDARY SOURCES 32 1.6.5 ASSUMPTIONS 33

2 EXECUTIVE SUMMARY 34

3 PREMIUM INSIGHTS 37 3.1 GLOBAL MICROFLUIDICS MARKET, A SNAPSHOT (2013) 37 3.2 MARKET DYNAMICS 38 3.3 MICROFLUIDICS MARKET, BY INDUSTRY 39 3.4 MICROFLUIDICS MARKET, BY APPLICATIONS 40 3.5 GEOGRAPHIC ANALYSIS & MATERIALS MARKET 41

4 MARKET OVERVIEW 42 4.1 INTRODUCTION 43 4.2 MARKET SEGMENTATION 44 4.3 MARKET DYNAMICS 46 4.3.1 DRIVERS 46 4.3.1.1 Rising demand for Point-of-Care (POC) testing to drive the market 46 4.3.1.2 Quick return on investments helping in cost reductions 46 4.3.1.3 Microfluidic chips miniaturization helps to reduce testing time and cost 46 4.3.2 RESTRAINTS 47 4.3.2.1 The incorporation of emerging microfluidic technology into existing workflows is challenging 47 4.3.2.2 Complex and time consuming regulatory standards to lengthen the approval process 47 4.3.3 OPPORTUNITIES 48 4.3.3.1 Growing Asian market 48 4.3.3.2 Shifting trend towards polymers adoption 48 4.3.3.3 Expanding applications of drug delivery technologies 49 4.3.4 TRENDS 49 4.3.4.1 Increasing number of patent applications 49 4.3.5 CHALLENGES FOR MANUFACTURERS 50 4.3.5.1 Geometrical issues 50 4.3.5.2 Surface chemistry issues 50 4.3.6 WINNING IMPERATIVES 51 4.3.6.1 Standardization 51 4.3.6.2 Compatibility 51 4.4 STRATEGIC BENCHMARKING 52 4.4.1 TECHNOLOGY INTEGRATION & PRODUCT ENHANCEMENT 53 4.4.1.1 Collaboration between Fluidigm Corporation and Olink Bioscience 53 4.4.1.2 Agreement between Agilent Technologies, Inc. and Caliper Life Sciences, Inc. 53 4.4.1.3 Agreement between PerkinElmer and GenMark Diagnostics, Inc. 53 4.4.1.4 Collaboration between Roche Diagnostics and Immatics Biotechnologies GmbH 54 4.4.1.5 Agreement between RainDance Technologies and Myriad Genetics, Inc. 54

5 MICROFLUIDICS MARKET, BY MATERIAL 55 5.1 INTRODUCTION 56 5.2 POLYMER-BASED MICROFLUIDICS 60 5.3 GLASS-BASED MICROFLUIDICS 62 5.4 SILICON-BASED MICROFLUIDICS 64 5.5 OTHER MATERIALS-BASED (PAPER & CERAMICS) MICROFLUIDICS 66

6 MICROFLUIDIC DEVICES MARKET, BY INDUSTRY 68 6.1 INTRODUCTION 69 6.2 PHARMACEUTICALS 73 6.2.1 MICROFLUIDIC CHIPS FOR LAB ANALYTICS 75 6.2.1.1 Toxicity screening 77 6.2.1.2 Proteomic analysis 79 6.2.1.3 Gene sequencing 80 6.2.1.4 Capillary electrophoresis 82 6.2.2 ACCURATE DISPENSING DEVICES 83 6.2.3 MICROREACTORS FOR DRUG SYNTHESIS 84 6.3 IN-VITRO DIAGNOSTICS 86 6.3.1 CLINICAL DIAGNOSTICS 87 6.3.2 POINT-OF-CARE (POC) 89 6.3.3 ENVIRONMENTAL TESTING 90 6.3.4 INDUSTRIAL TESTING 91 6.3.5 AGRO FOOD TESTING 92 6.4 DRUG DELIVERY DEVICES 94 6.4.1 INHALER NOZZLES 95 6.4.2 MICRONEEDLES 97 6.4.3 MICROPUMPS 98

7 MICROFLUIDICS DEVICES MARKET, BY APPLICATIONS 100 7.1 INTRODUCTION 101 7.2 DRUG DELIVERY 103 7.3 INDUSTRIAL & ENVIRONMENTAL 104 7.4 ANALYSIS (TOXICITY SCREENING, PROTEOMIC ANALYSIS & GENE SEQUENCING) 106 7.5 PHARMACEUTICAL & LIFE SCIENCE RESEARCH 107 7.6 POINT OF CARE DIAGNOSTICS 109 7.7 CLINICAL & VETERINARY DIAGNOSTICS 110

8 GEOGRAPHIC ANALYSIS 112 8.1 INTRODUCTION 113 8.2 NORTH AMERICA 116 8.3 EUROPE 125 8.4 ASIA 134 8.5 REST OF THE WORLD (ROW) 143

9 COMPETITIVE LANDSCAPE 150 9.1 INTRODUCTION 150 9.2 MERGERS & ACQUISITIONS 151 9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES 153 9.4 NEW PRODUCT LAUNCHES 154 9.5 EXPANSION 156 9.6 APPROVALS 157

10 COMPANY PROFILES 158 10.1 ABBOTT LABORATORIES, INC. 158 10.2 AGILENT TECHNOLOGIES 165 10.3 PERKINELMER, INC. 171 10.4 BARTELS MIKROTECHNIK GMBH 178 10.5 SCIENION AG 181 10.6 CEPHEID, INC. 185 10.7 FLUIDIGM CORPORATION 191 10.8 RAINDANCE TECHNOLOGIES 199 10.9 BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE 204 10.10 BIO-RAD LABORATORIES, INC. 210 10.11 BIOFLUIDIX GMBH 215 10.12 DANAHER CORPORATION 217 10.13 JOHNSON & JOHNSON 222 10.14 LIFE TECHNOLOGIES CORPORATION 228 10.15 MICROFLUIDIC CHIPSHOP GMBH 234 10.16 ROCHE DIAGNOSTICS LIMITED 236 10.17 SIEMENS HEALTHCARE 242

COMPETITIVE DEVELOPMENTS (2011-2013) 248

LIST OF TABLES TABLE 1 GLOBAL MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 35 TABLE 2 GLOBAL MICROFLUIDIC MATERIALS MARKET: REVENUE, BY TYPE, 2011-2018 ($MILLION) 58 TABLE 3 MICROFLUIDIC MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 59 TABLE 4 POLYMER-BASED MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 61 TABLE 5 GLASS-BASED MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 63 TABLE 6 SILICON-BASED MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 65 TABLE 7 PAPER & CERAMICS-BASED MATERIALS MARKET: REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 67 TABLE 8 MICROFLUIDICS PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 72 TABLE 9 MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 74 TABLE 10 MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 75 TABLE 11 MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 76 TABLE 12 MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 77 TABLE 13 MICROFLUIDIC CHIPS FOR TOXICITY SCREENING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 78 TABLE 14 MICROFLUIDIC CHIPS FOR PROTEOMIC ANALYSIS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 80 TABLE 15 MICROFLUIDIC CHIPS FOR GENE SEQUENCING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 81 TABLE 16 MICROFLUIDIC CHIPS FOR CAPILLARY ELECTROPHORESIS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 82 TABLE 17 MICROFLUIDIC ACCURATE DISPENSING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 83 TABLE 18 MICROFLUIDIC MICROREACTORS FOR DRUG SYNTHESIS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 85 TABLE 19 MICROFLUIDIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 86 TABLE 20 MICROFLUIDIC IN-VITRO DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 87 TABLE 21 MICROFLUIDIC CLINICAL DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 88 TABLE 22 MICROFLUIDICS POINT OF CARE MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 90 TABLE 23 MICROFLUIDIC ENVIRONMENTAL TESTING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 91 TABLE 24 MICROFLUIDIC INDUSTRIAL TESTING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 92 TABLE 25 MICROFLUIDIC AGRO FOOD TESTING MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 93 TABLE 26 MICROFLUIDIC DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 94 TABLE 27 MICROFLUIDIC DRUG DELIVERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 95 TABLE 28 MICROFLUIDIC INHALER NOZZLES MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 96 TABLE 29 MICROFLUIDIC MICRONEEDLES MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 97 TABLE 30 MICROFLUIDIC MICROPUMPS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 98 TABLE 31 GLOBAL MICROFLUIDICS APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 102 TABLE 32 MICROFLUIDICS DRUG DELIVERY APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 103 TABLE 33 MICROFLUIDICS INDUSTRIAL & ENVIRONMENTAL APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 105 TABLE 34 MICROFLUIDICS ANALYSIS APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 106 TABLE 35 MICROFLUIDICS PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 108 TABLE 36 MICROFLUIDICS POINT OF CARE DIAGNOSTICS APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 110 TABLE 37 MICROFLUIDICS CLINICAL & VETERINARY DIAGNOSTICS APPLICATIONS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 111 TABLE 38 GLOBAL MICROFLUIDICS MARKET REVENUE, BY GEOGRAPHY, 2011-2018 ($MILLION) 115 TABLE 39 NORTH AMERICA: MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 118 TABLE 40 NORTH AMERICA: MICROFLUIDIC PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 119 TABLE 41 NORTH AMERICA: MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 120 TABLE 42 NORTH AMERICA: MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 121 TABLE 43 NORTH AMERICA: MICROFLUIDICS IVD MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 122 TABLE 44 NORTH AMERICA: MICROFLUIDIC DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 123 TABLE 45 NORTH AMERICA: MICROFLUIDICS APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 124 TABLE 46 EUROPE: MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 127 TABLE 47 EUROPE: MICROFLUIDIC PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 128 TABLE 48 EUROPE: MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 129 TABLE 49 EUROPE: MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 130 TABLE 50 EUROPE: MICROFLUIDICS IVD MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 131 TABLE 51 EUROPE: MICROFLUIDICS DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 132 TABLE 52 EUROPE: MICROFLUIDICS APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 133 TABLE 53 ASIA: MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 136 TABLE 54 ASIA: MICROFLUIDIC PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 137 TABLE 55 ASIA: MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 138 TABLE 56 ASIA: MICROFLUIDICS CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 139 TABLE 57 ASIA: MICROFLUIDICS IVD MARKET REVENUE, BY PRODUCTS, 2011-2018 ($MILLION) 140 TABLE 58 ASIA: MICROFLUIDICS DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 141 TABLE 59 ASIA: MICROFLUIDICS APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 142 TABLE 60 ROW: MICROFLUIDIC MATERIALS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 144 TABLE 61 ROW: MICROFLUIDIC PRODUCTS MARKET REVENUE, BY INDUSTRY, 2011-2018 ($MILLION) 145 TABLE 62 ROW: MICROFLUIDICS PHARMACEUTICAL PRODUCTS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 145 TABLE 63 ROW: MICROFLUIDIC CHIPS FOR LAB ANALYTICS MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 146 TABLE 64 ROW: MICROFLUIDICS IVD MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 147 TABLE 65 ROW: MICROFLUIDICS DRUG DELIVERY DEVICES MARKET REVENUE, BY PRODUCT, 2011-2018 ($MILLION) 148 TABLE 66 ROW: MICROFLUIDIC APPLICATIONS MARKET REVENUE, BY TYPE, 2011-2018 ($MILLION) 149 TABLE 67 MERGERS & ACQUISITIONS, 2011-2013 152 TABLE 68 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES, 2011-2013 153 TABLE 69 NEW PRODUCT LAUNCHES, 2011-2013 155 TABLE 70 EXPANSION, 2011-2012 156 TABLE 71 APPROVALS, 2013 157 TABLE 72 LIFE TECHNOLOGIES CORPORATION: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 229

LIST OF FIGURES FIGURE 1 MARKET CRACKDOWN & DATA TRIANGULATION METHODOLOGY FOR MICROFLUIDICS MARKET 29 FIGURE 2 MARKET FORECASTING MODEL 30 FIGURE 3 RESEARCH OUTPUT: 360O VALIDATION 31 FIGURE 4 GLOBAL MICROFLUIDICS MARKET, BY PRODUCTS, 2013-2018 ($MILLION) 36 FIGURE 5 GLOBAL MICROFLUIDICS MARKET, 2013 37 FIGURE 6 MICROFLUIDICS MARKET DYNAMICS 38 FIGURE 7 MICROFLUIDICS MARKET, BY INDUSTRY, 2013-2018 39 FIGURE 8 MICROFLUIDICS MARKET, BY APPLICATIONS, 2013 VS 2018 40 FIGURE 9 MICROFLUIDICS MARKET: GEOGRAPHIC ANALYSIS, 2013 ($MILLION) 41 FIGURE 10 MICROFLUIDICS MARKET SEGMENTATION 45 FIGURE 11 TECHNOLOGY ADOPTION & PRODUCT ENHANCEMENT 52 FIGURE 12 MICROFLUIDICS MARKET: BY MATERIALS, 2011-2018 (MARKET SIZE & GROWTH RATES) 57 FIGURE 13 GLOBAL POLYMERS MARKET COMPARISON, 2013 VS 2018 60 FIGURE 14 MICROFLUIDICS MARKET, BY PRODUCTS, 2013-2018 70 FIGURE 15 MICROFLUIDICS PRODUCTS MARKET REVENUE, BY INDUSTRY - A FOCUS ON IVD (2013) 71 FIGURE 16 GLOBAL MICROFLUIDICS MARKET, BY APPLICATIONS, 2013-2018 101 FIGURE 17 OPPORTUNITY MATRIX: MICROFLUIDICS MARKET, BY GEOGRAPHY, 2013-2018 114 FIGURE 18 KEY GROWTH STRATEGIES IN MICROFLUIDICS MARKET, 2011-2013 150 FIGURE 19 ABBOTT LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($BILLION) 159 FIGURE 20 ABBOTT LABORATORIES, INC.: GEOGRAPHIC REVENUE MIX, 2012 160 FIGURE 21 ABBOTT LABORATORIES, INC.: BUSINESS REVENUE MIX, 2012 160 FIGURE 22 ABBOTT LABORATORIES, INC.: MARKET STRATEGY, 2011-2013 162 FIGURE 23 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($BILLION) 166 FIGURE 24 AGILENT TECHNOLOGIES: BUSINESS REVENUE MIX, 2012 167 FIGURE 25 AGILENT TECHNOLOGIES: MARKET STRATEGY, 2010-2012 169 FIGURE 26 PERKINELMER, INC.: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($BILLION) 172 FIGURE 27 PERKINELMER, INC.: GEOGRAPHIC REVENUE MIX, 2012 172 FIGURE 28 PERKINELMER, INC.: BUSINESS REVENUE MIX, 2012 173 FIGURE 29 PERKINELMER, INC.: MARKET STRATEGY, 2011-2012 176 FIGURE 30 SCIENION AG: MARKET STRATEGY, 2012-2013 183 FIGURE 31 CEPHEID, INC.: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($MILLION) 186 FIGURE 32 CEPHEID, INC.: GEOGRAPHIC REVENUE MIX, 2012 186 FIGURE 33 CEPHEID, INC.: BUSINESS REVENUE MIX, 2012 187 FIGURE 34 CEPHEID, INC.: MARKET STRATEGY, 2011-2013 188 FIGURE 35 FLUIDIGM CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2010-2012 ($MILLION) 192 FIGURE 36 FLUIDIGM CORPORATION: GEOGRAPHIC REVENUE MIX, 2012 193 FIGURE 37 FLUIDIGM CORPORATION: BUSINESS REVENUE MIX, 2012 193 FIGURE 38 FLUIDIGM CORPORATION: MARKET STRATEGY, 2011-2013 195 FIGURE 39 RAINDANCE TECHNOLOGIES: MARKET STRATEGY, 2011-2013 201 FIGURE 40 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 205 FIGURE 41 BD DIAGNOSTICS: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 206 FIGURE 42 BECTON, DICKINSON AND COMPANY: MARKET STRATEGY, 2011-2013 207 FIGURE 43 BIO-RAD LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 211 FIGURE 44 BIO-RAD LABORATORIES, INC.: MARKET SRATEGY, 2011-2013 213 FIGURE 45 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 218 FIGURE 46 DANAHER CORPORATION: MARKET STRATEGY, 2011-2013 220 FIGURE 47 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLLION) 223 FIGURE 48 JOHNSON & JOHNSON: DIAGNOSTICS FRANCHISE REVENUE, 2010-2012 ($MILLION) 224 FIGURE 49 JOHNSON & JOHNSON: MARKET STRATEGY, 2011-2013 226 FIGURE 50 LIFE TECHNOLOGIES CORPORATION: MARKET STRATEGY, 2012-2013 232 FIGURE 51 ROCHE HOLDINGS: DIAGNOSTICS REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 237 FIGURE 52 ROCHE HOLDINGS: DIAGNOSTICS REVENUE, BY GEOGRAPHY, 2010-2012 ($MILLION) 238 FIGURE 53 ROCHE HOLDINGS: MARKET STRATEGY, 2011-2013 240 FIGURE 54 SIEMENS AG: TOTAL REVENUE, BY SEGMENT, 2010-2012 ($MILLION) 243 FIGURE 55 SIEMENS HEALTHCARE: MARKET STRATEGY, 2011-2013 245

To order this report: Forecast to 2018 utm_campaign=In_Vitro_Diagnostic

__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

SOURCE Reportlinker
COPYRIGHT 2013 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018.
Publication:PR Newswire
Geographic Code:100NA
Date:Dec 31, 2013
Words:3045
Previous Article:MediPoint: Cardiac Rhythm Management - EU Analysis and Market Forecasts.
Next Article:MediPoint: Cardiac Rhythm Management - APAC Analysis and Market Forecasts.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters